nicotinamide: Clinical Trials

6 trials of nicotinamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 recruiting. 6 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 4, Recruiting 2
Phase 22Completed 2

Follow nicotinamide: new trials by email Literature Review of nicotinamide trials Research Report on nicotinamide

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Evaluation of Nicotine Analogs
Biospecimen Collection, Nicotine, 6-Methyl Nicotine - Tobacco-Related Carcinoma, Addiction
Phase 1RecruitingOhio State University Comprehensive Cancer Center702026-05-292026-06-26
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
Nicotinamide - Sickle Cell Disease
Phase 1RecruitingEpiDestiny, Inc.202020-01-242026-09-30
Healthy Combine Study
Nicotinamide, Lanthanum Carbonate, Lanthanum Carbonate Placebo - Healthy
Phase 1CompletedNorthwestern University392016-02-032024-02-23
Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies
Vorinostat, Niacinamide, Etoposide - Hodgkin's Disease, Non-Hodgkin's Lymphoma
Phase 1CompletedColumbia University402008-06-012020-11-20
Safety Study of Nicotinamide to Treat Alzheimer's Disease
Nicotinamide, Enduramide placebo - Alzheimer's Disease
Phase 1 / Phase 2CompletedUniversity of California, Irvine502008-01-012017-01-25
Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety
Psilocybin (drug), Niacin, MRI - Anxiety
Phase 1 / Phase 2CompletedLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center122004-04-012025-03-13

Conditions studied

Alzheimer Disease (1)  ·  Anemia, Sickle Cell (1)  ·  Anxiety Disorders (1)  ·  Behavior, Addictive (1)  ·  Dementia (1)  ·  Depression (1)  ·  Hodgkin Disease (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Neoplasms (1)

Sponsors

Columbia University (1)  ·  EpiDestiny, Inc. (1)  ·  Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1)  ·  Northwestern University (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  University of California, Irvine (1)

Countries

United States (6)

Top investigators

Charles S. Grob, MD (1)  ·  Owen A O'Connor, MD, Ph.D. (1)  ·  Robert Molokie (1)  ·  Steven S Schreiber, MD (1)  ·  Tamara Isakova, MD, MMSc (1)  ·  Theodore L Wagener, PhD (1)

Results publications

PMID 20819978, PMID 23913470